Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Collegium completes venture financing

    Collegium Pharmaceutical Inc., Canton, Mass. Business: Drug delivery, Neurology, Inflammation Date completed: 2015-03-10 Type: Venture financing Raised: $50 million Investors: TPG Biotech; RA Capital Management; Adage …

    Published on 3/16/2015
  • Dyadic International Inc completes private placement of subordinated notes

    Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla. Business: Genomics, Supply/Service, Biomanufacturing Date completed: 2015-03-09 Type: Private placement of subordinated notes Raised: $2 million Investor: Existing …

    Published on 3/16/2015
  • Galena Biopharma Inc completes follow-on

    Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore. Business: Cancer Date completed: 2015-03-13 Type: Follow-on Raised: $38 million Units: 24.4 million Price: $1.56 (unit) Shares after offering: 153.8 million …

    Published on 3/16/2015
  • Genocea Biosciences Inc completes follow-on

    Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Business: Infectious Date completed: 2015-03-12 Type: Follow-on Raised: $45 million Shares: 5.5 million Price: $8.25 Shares after offering: 23.3 million …

    Published on 3/16/2015
  • GrayBug completes venture financing

    GrayBug Inc., Baltimore, Md. Business: Drug delivery, Ophthalmic Date completed: 2015-03-10 Type: Venture financing Raised: $1.7 million Investors: Hatteras Funds; Maryland Venture Fund Note: The financing is a series A…

    Published on 3/16/2015
  • Heat Biologics Inc completes follow-on

    Heat Biologics Inc. (NASDAQ:HTBX), Chapel Hill, N.C. Business: Cancer, Inflammation, Infectious Date completed: 2015-03-10 Type: Follow-on Raised: $10.7 million Shares: 1.6 million Price: $6.50 Shares after offering: 8.…

    Published on 3/16/2015
  • Inflection Biosciences completes venture financing

    Inflection Biosciences Ltd., Blackrock, Ireland Business: Cancer Date completed: 2015-03-09 Type: Venture financing Raised: EUR725,000 ($786,988) Investors: New investors; existing investors Note: The financing includes…

    Published on 3/16/2015
  • Kura Oncology completes venture financing

    Kura Oncology Inc., La Jolla, Calif. Business: Cancer Date completed: 2015-03-12 Type: Venture financing Raised: $60 million Placement agents: Leerink; National Securities; Livingston Securities Investors: EcoR1 Capital…

    Published on 3/16/2015
  • Kythera Biopharmaceuticals Inc completes follow-on

    Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH), Calabasas, Calif. Business: Dermatology Date completed: 2015-03-10 Type: Follow-on Raised: $125 million Shares: 2.6 million Price: $48 Shares after offering: 25.3 million …

    Published on 3/16/2015
  • Minerva Neurosciences Inc completes private placement of common stock and warrants

    Minerva Neurosciences Inc. (NASDAQ:NERV), Cambridge, Mass. Business: Neurology Date completed: 2015-03-13 Type: Private placement of common stock and warrants Raised: $31 million Shares: 6.3 million Price: $4.81 Shares …

    Published on 3/16/2015
  • PhaseBio completes venture financing

    PhaseBio Pharmaceuticals Inc., Malvern, Pa. Business: Drug delivery, Biomanufacturing Date completed: 2015-03-12 Type: Venture financing Raised: $40 million Investors: AstraZeneca plc; New Enterprise Associates; …

    Published on 3/16/2015
  • Portola Pharmaceuticals Inc completes follow-on

    Portola Pharmaceuticals Inc. (NASDAQ:PTLA), South San Francisco, Calif. Business: Cardiovascular, Cancer, Hematology Date completed: 2015-03-10 Type: Follow-on Raised: $99.8 million Shares: 2.5 million Price: $40 Shares…

    Published on 3/16/2015
  • TapImmune Inc completes private placement of units

    TapImmune Inc. (OTCBB:TPIV), Seattle, Wash. Business: Cancer, Infectious Date completed: 2015-03-10 Type: Private placement of units Raised: $1 million Units: 5 million Price: $0.20 (unit) Shares after offering: 32.6 …

    Published on 3/16/2015
  • Tetraphase Pharmaceuticals Inc completes follow-on

    Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH), Watertown, Mass. Business: Infectious Date completed: 2015-03-11 Type: Follow-on Raised: $150.5 million Shares: 4.3 million Price: $35 Shares after offering: 35.3 million …

    Published on 3/16/2015
  • Tobira completes venture financing

    Tobira Therapeutics Inc., San Francisco, Calif. Business: Infectious Date completed: 2015-03-09 Type: Venture financing Raised: $13 million Investors: Abingworth Management; Biotechnology Value Fund; Stonepine Capital; …

    Published on 3/16/2015
  • Veniti completes venture financing

    Veniti Inc., St. Louis, Mo. Business: Cardiovascular Date completed: 2015-03-10 Type: Venture financing Raised: $17 million Investors: Baird Capital; Tekla Healthcare; Tekla Life Science Investors; Life Sciences …

    Published on 3/16/2015
  • BioLineRx Ltd financial update

    BioLineRx Ltd. (Tel Aviv:BLRX; NASDAQ:BLRX), Jerusalem, Israel Business: Neurology, Cardiovascular, Infectious Date announced: 2015-03-11 Note: BioLineRx raised $3.8 million through the sale of 1.9 million ADSs at $2 to…

    Published on 3/16/2015
  • Depomed Inc financial update

    Depomed Inc. (NASDAQ:DEPO), Newark, Calif. Business: Endocrine/Metabolic, Neurology, Drug delivery Date announced: 2015-03-12 Note: Depomed secured a $575 million debt facility from Deerfield and Pharmakon. The seven-…

    Published on 3/16/2015
  • Eleven Biotherapeutics Inc financial update

    Eleven Biotherapeutics Inc. (NASDAQ:EBIO), Cambridge, Mass. Business: Ophthalmic Date announced: 2015-03-11 Note: Eleven Biotherapeutics established an at-the-market program to sell up to $40 million of its common stock…

    Published on 3/16/2015
  • Intra-Cellular Therapies Inc financial update

    Intra-Cellular Therapies Inc. (NASDAQ:ITCI), New York, N.Y. Business: Neurology Date announced: 2015-03-11 Note: Intra-Cellular raised $15.9 million through the sale of 661,481 shares at $24 to cover the overallotment …

    Published on 3/16/2015
  • Tesaro Inc financial update

    Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. Business: Cancer Date announced: 2015-03-09 Note: Tesaro raised $18.1 million through the sale of 355,000 shares at $51 to cover the overallotment from its March 3 follow-on, …

    Published on 3/16/2015
  • TPG Biologics financial update

    TPG Biologics Inc., Taipei, Taiwan Business: Antibodies, Supply/Service Date announced: 2015-03-11 Note: TPG Biologics began the formal process to list on the GreTai Securities Market in Taiwan by applying as an …

    Published on 3/16/2015
  • Aduro Biotech proposes IPO

    Aduro Biotech Inc., Berkeley, Calif. Business: Cancer Date announced: 2015-03-11 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: BofA Merrill Lynch; Leerink Partners; William Blair; …

    Published on 3/16/2015
  • Allergy Therapeutics pl proposes placing

    Allergy Therapeutics plc (LSE:AGY), London, U.K. Business: Inflammation Date announced: 2015-03-10 Type: Placing To be raised: Up to L20.8 million ($31.5 million) Shares: 94.1 million Price: 22.1p Shares outstanding …

    Published on 3/16/2015
  • KemPharm proposes IPO

    KemPharm Inc., Coralville, Iowa Business: Neurology Date announced: 2015-03-11 Type: IPO To be raised: Up to $57.5 million Shares: TBD Price: TBD Underwriters: Cowen; RBC Capital Markets; Canaccord; Oppenheimer …

    Published on 3/16/2015

< Previous   1  2  3  4  5  6  7  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993